Nektar Therapeutics | NKTR - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Agios Pharmaceuticals USD 1.32M 560K 2026-03
ALKERMES USD 73.25M 27.04M 2026-03
Amgen USD 1.6B 187M 2026-03
Baxter International USD 1.81B 587M 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Cara Therapeutics USD 0 0 2025-03
Cipla INR 26.32B 2.79B 2026-03
Dr.Reddys Laboratories INR 37.7B 1.54B 2026-03
Eisai JPY 52.02B 931M 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Exelixis USD 19.95M 6.53M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Grifols EUR 1.51B 184.45M 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 2.94B 380M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Takeda JPY 560.54B 159.39B 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Xencor USD 61.66M 50.95M 2025-06